Skip to content
Coronavirus, Variants, and Vaccines
Go to my account

Coronavirus, Variants, and Vaccines

We heard from many of you that you are having trouble persuading people close to ...

We heard from many of you that you are having trouble persuading people close to you to take the COVID vaccine. You wished there was something you could pass along to people with the actual facts about the vaccine, not scary myths about why a person should not get it. You asked, and we listened. Former CDC Director Dr. Tom Frieden joined Sarah and Andrew Egger (subbing in for Steve) to discuss all things vaccine related. Not only is Frieden an expert on the COVID vaccines, but also on listening to those who are concerned about taking it and trying to give them the scientific facts that support getting the shot. As he says, “Effective communication starts with listening. … I understand your concern, but I’ll share with you some information that may be helpful to you.”

Show Notes:

Listen on your player of choice

Sarah Isgur is a senior editor at The Dispatch and is based in northern Virginia. Prior to joining the company in 2019, she had worked in every branch of the federal government and on three presidential campaigns. When Sarah is not hosting podcasts or writing newsletters, she’s probably sending uplifting stories about spiders to Jonah, who only pretends to love all animals.

Please note that we at The Dispatch hold ourselves, our work, and our commenters to a higher standard than other places on the internet. We welcome comments that foster genuine debate or discussion—including comments critical of us or our work—but responses that include ad hominem attacks on fellow Dispatch members or are intended to stoke fear and anger may be moderated.

You are currently using a limited time guest pass and do not have access to commenting. Consider subscribing to join the conversation.

With your membership, you only have the ability to comment on The Morning Dispatch articles. Consider upgrading to join the conversation everywhere.